back to overview


TytoCare closes $50 million round as the demand for telehealth accelerates

April 09, 2020 + Jessica Di Palo
5 Min read

The $50 million round will support the TytoCare to continue to scale business activities globally, as well as respond to the increase in demand for their digital health solutions.

Tytocare closes investment round

MTIP, the pan-European specialist Healthtech investor, took part in the newest financing round for Fund I Portfolio Company TytoCare. The $50 million round will support the Company to continue to scale business activities globally, as well as respond to the increase in demand for their digital health solutions.

In these troubling times caused by COVID-19, when we all face social isolation and governments impose restrictions upon us, we need to constantly monitor these impacts on our selected portfolio companies. As the demand for telehealth is accelerating, we are proud that TytoCare, the healthcare industry’s first all-in-one modular device and telehealth platform for on-demand, remote medical examinations, closed a financing round of $50 million, bringing the Company’s total capital raised to more than $105 million.

TytoCare’s product TytoHomean easy to use toolkit that offers on-demand medical exams for patients, is a unique telehealth diagnostic solution. The Israeli digital health Company allows patients to selfmonitor, and the data to be sent remotely to physicians, allowing them to oversee patients without exposure to a disease. In Switzerland the health inscurance Company SWICA will be testing TytoHome with 2000 of their customers until the end of 2020. The insurer reports that their pilot project has been very popular and that all devices have been successfully assigned. 

«This round of financing will allow Tyto Care to focus even more on the needs of patients to develop new devices that build on their telehealth platform», said Dr. Christoph Kausch Managing Partner of MTIP. He adds: «Furthermore, we see the Company’s development as a confirmation of our investment thesis». MTIP recognized several years ago that the system was not able to keep up with demand, and the healthcare sector would need to innovate and leverage new technologies to continue to operate at a sustainable level. One of the key pillars of MTIP’s investment thesis is the need for decentralizationIn an environment where we are all isolated in our homes, it is companies like TytoCare that are of particular necessity. MTIP is confident in the defensiveness of the Healthtech sector and our ability to continue to make successful investments throughout the cycle. It is with great pleasure that we look back on the previous relationship between TytoCare and MTIP and look forward to how this symbiosis will continue to grow in the future.

As TytoCare CEO and Co-founder Dedi Gilad noted: «MTIP has played and will continue to play a vital role in opening doors and creating potential partnerships throughout EuropeBuilding on the success and excitement for TytoCare in the US, we are pleased to be partnering with such a knowledgeable digital health investor whose unique position will help us further transform telehealth and reach more homes around the globe, especially in Europe.»

Share the Article


Dealroom Report: Tooling the Physicians of the Future

European startups addressing clinical capacity bottlenecks


MTIP Office Featured in Swiss Office Blog

MTIP Office Featured in Swiss Office Blog


Diversity, Equity, and Inclusion: The 3 Key Drivers for Success

We have talked with Caroline Noublanche, CEO of our portfolio company Apricity, about her company’s DEI efforts.


Growth Capital Decisions – An Interview with our Co-Founder & Managing Partner Dr. Christoph Kausch

Growth Capital Decisions


Rahel Hafner Receives Certificate in ESG Investing by CFA Institute

Rahel Hafner Receives Certificate in ESG Investing


What Makes a Great Founder/Investor Relationship?

Interview with the CEO and Co-Founder Kai Eberhardt of our portfolio company Oviva


MTIP’s HealthCare Clinic 2022

This year's HealthCare Clinic was held under the motto: "Surfing the Healthtech Waves of Change".


Christoph Kausch selected by Real Deals as most influential for 2022

Christoph Kausch named by Real Deals most influential for 2022


MTIP leads €17 million financing round in virtual fertility clinic Apricity

New MTIP investment


MTIP leads the €20 million growth financing round in LynxCare

Largest capital round ever in digital health in Belgium


Pioneering the use of machine learning algorithms to turbo-charge drug development

Intelligencia revolutionizes drug development


The psychology of decision making

What makes a good investor?


Revolutionizing medical triage with artificial intelligence

Mediktor's solution for medical triage


MTIP Closes Second Healthtech Growth Fund Above Target With $250M of Commitments

MTIP Fund II is closed!


Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics

Cynerio's new product Cynerio Now!


MTIP invests in Mediktor

New investment in Mediktor


SFDR Art. 8 or Art. 9? What’s the difference?

SFDR: getting the terminology right


MTIP participates in Oviva’s new $80m Series C funding

Oviva raises $80 million financing round


MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

MTIP's new investment in Intelligencia


Private Equity 101: Part one – Glossary

Are you new to the healthtech space?


Leading brands revolutionize care journeys with Lumeon

How Lumeon orchestrates care journey


Trialbee – our hero in patient matching and recruiting for clinical trials

Trialbee - patient matching and recruiting

news blog

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations


MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II